Bio Nebraska and PhRMA will host a special briefing on COVID-19 Research & Development for Nebraska Legislators and Policymakers.
Oct, 7, 2020 from 1:00 pm – 2:00 pm CDT
Attendees will hear from a panel of experts on the ongoing fight against the novel coronavirus and how Nebraska researchers, scientists and biopharmaceutical companies are at the forefront of the battle as they work toward preventative measures and developing treatments and therapies to aid patients infected with COVID-19.
Panelists include:
Jeffrey P. Gold, MD
Chancellor, UNO and UNMC
David Hild
Senior Vice President and General Manager, ADS Biotec
Sharon Lamberton, MS, RN
Deputy Vice President of State Policy, PhRMA
Tyler Martin, MD
Chief Executive Officer, Adjuvance Technologies
Rob Owen
Executive Director, Bio Nebraska